SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-089158
Filing Date
2020-07-31
Accepted
2020-07-31 17:10:22
Documents
1
Period of Report
2020-07-26

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2025773d1_4.html 4  
1 OWNERSHIP DOCUMENT tm2025773d1_4.xml 4 4651
  Complete submission text file 0001104659-20-089158.txt   6359
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Issuer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 110 EAST 59TH STREET NEW YORK NY 10019
Business Address
Lebovits Chaim (Reporting) CIK: 0001406302 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36641 | Film No.: 201066830